Oncology
Prof. Dr. med. Ingo Schmidt-Wolf
Director of the Integrated Oncology Department, University Clinic Bonn
Oncology
Director of the Integrated Oncology Department, University Clinic Bonn
Professor Schmidt-Wolf heads an oncology department at a university medicine center (i.e., a top-level healthcare facility in Germany), which is in many ways unique. The concept of the Center for Integrated Oncology (CIO) is a holistic approach to the treatment of each individual patient, as well as cancer prevention, including traditional measures such as healthy diet and sports.
Within this concept, it is a German healthcare standard that CIO is part of the Bonn University Hospital, a complex of facilities dealing with all types of cancer: hematology, neuro-oncology, radiology and nuclear medicine, various surgery specialties, pediatrics, palliative medicine and gerontology. Notably, Professor Schmidt-Wolf’s innovative ideas are applied in the development and use of fundamentally new cancer therapies, not typical of conventional German oncology.
The main focus of the department head and his team is research in the field of molecular and immune therapies.
In terms of molecular therapies, the professor concentrates on two main areas:
- the development and application of two-component drugs that simultaneously detect and "exterminate" tumor cells;
- the use of killer T cells to treat hematologic neoplasms as part of stem cell transplantation procedure, both to increase the immune response and suppress a specific target.
In the field of immune therapy, Professor Schmidt-Wolf specializes in the development of multiclonal cytotoxic T-cell substances that neutralize pancreatic cancer cells. Innovative research and drug trials are also being conducted in the treatment of metastatic renal cell carcinoma.
Thus, the Center for Integrated Oncology fosters the use of totally new and more effective drugs developed through experimental immunological research. In doing so, Professor Schmidt-Wolf and his team accumulate the results of similar scientific research conducted by three other major cancer centers in Germany – at the universities of Cologne, Aachen and Düsseldorf, which are acting as one team under the slogan "Together against Cancer. Together for Life".
Immunological diseases.
Hematological and oncological diseases.
Diagnosis and therapy of malignant lymphoma.
Treatment of solid tumors.
Acute and chronic leukemia.
Reviews
Zeinab
Professor’s consultation was indeed a blessing, he pointed out that the way my lymphoma developed was contradictory to the diagnosis of highly aggressive type that a had got from my cancer care provider. He suggested I should have my slides reviewed at a specialized lab, and it proved the initial histology wrong! In fact, it made a big difference in terms of my therapy plan, making a severe chemo regimen useless. Thank you, dear Professor!
Команда MedConsOnline
Dear Zeinab, Thanks a lot for your review, we are glad that you could benefit from your cancer second opinion consul with Prof. Schmidt-Wolf. We wish you all the best. Best regards, Your MedconsOnline Manager